User profiles for "author:Yi-Hsing Chen"
Yi-Hsing ChenTaichung Veterans General Hospital Verified email at vghtc.gov.tw Cited by 4362 |
[HTML][HTML] Autoantibodies in idiopathic inflammatory myopathies: clinical associations and laboratory evaluation by mono-and multispecific immunoassays
J Damoiseaux, JB Vulsteke, CW Tseng… - Autoimmunity …, 2019 - Elsevier
Idiopathic inflammatory myopathies (IIM) are a group of diseases characterized by immune-
mediated muscular lesions that may be associated with extra-muscular manifestations …
mediated muscular lesions that may be associated with extra-muscular manifestations …
Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor …
Objective To investigate the kinetics of hepatitis B virus (HBV) viral loads and HBV
reactivation in rheumatoid arthritis (RA) patients undergoing therapy with tumour necrosis …
reactivation in rheumatoid arthritis (RA) patients undergoing therapy with tumour necrosis …
APLAR recommendations on the practice of telemedicine in rheumatology
S Ahmed, R Grainger, A Santosa… - International Journal …, 2022 - Wiley Online Library
Introduction The COVID‐19 pandemic led to rapid and widespread adoption of telemedicine
in rheumatology care. The Asia Pacific League of Associations for Rheumatology (APLAR) …
in rheumatology care. The Asia Pacific League of Associations for Rheumatology (APLAR) …
Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial
JR Curtis, K Yamaoka, YH Chen, DL Bhatt… - Annals of the …, 2023 - ard.bmj.com
Objectives To evaluate malignancies and their associations with baseline risk factors and
cardiovascular risk scores with tofacitinib versus tumour necrosis factor inhibitors (TNFi) in …
cardiovascular risk scores with tofacitinib versus tumour necrosis factor inhibitors (TNFi) in …
Intravitreal anti-vascular endothelial growth factor treatment for retinopathy of prematurity: comparison between ranibizumab and bevacizumab
Purpose: To compare the effect and the treatment outcomes of bevacizumab and
ranibizumab in the treatment of Type 1 retinopathy of prematurity (ROP). Methods: This was …
ranibizumab in the treatment of Type 1 retinopathy of prematurity (ROP). Methods: This was …
Significant associations of antidrug antibody levels with serum drug trough levels and therapeutic response of adalimumab and etanercept treatment in rheumatoid …
Objective To evaluate the associations between (1) antidrug antibody (ADAb) and
therapeutic response,(2) ADAb and serum drug trough levels and (3) serum drug levels and …
therapeutic response,(2) ADAb and serum drug trough levels and (3) serum drug levels and …
[HTML][HTML] CD4+ T-Cell Plasticity in Non-Infectious Retinal Inflammatory Disease
YH Chen, S Lightman, VL Calder - International Journal of Molecular …, 2021 - mdpi.com
Non-infectious uveitis (NIU) is a potentially sight-threatening disease. Effector CD4+ T cells,
especially interferon-γ-(IFNγ) producing Th1 cells and interleukin-17-(IL-17) producing Th17 …
especially interferon-γ-(IFNγ) producing Th1 cells and interleukin-17-(IL-17) producing Th17 …
Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study
Objective. SLE is associated with increased risk of diabetes mellitus. Treatment for SLE
requires high-dose glucocorticoids that may worsen glucose homoeostasis. HCQ can …
requires high-dose glucocorticoids that may worsen glucose homoeostasis. HCQ can …
[HTML][HTML] The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled …
MC Hsieh, WH Tsai, YP Jheng, SL Su, SY Wang… - Scientific reports, 2018 - nature.com
Probiotics have been reported to ameliorate symptoms of type 2 diabetes mellitus (T2DM) in
animal models and human studies. We previously demonstrated that oral administration of …
animal models and human studies. We previously demonstrated that oral administration of …
[HTML][HTML] Lactobacillus pentosus GMNL-77 inhibits skin lesions in imiquimod-induced psoriasis-like mice
YH Chen, CS Wu, YH Chao, CC Lin, HY Tsai… - journal of food and drug …, 2017 - Elsevier
Psoriasis, which is regarded as a T-cell-mediated chronic inflammatory skin disease, is
characterized by hyperproliferation and poor differentiation of epidermal keratinocytes. In …
characterized by hyperproliferation and poor differentiation of epidermal keratinocytes. In …